Kite Pharma is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Trademark Applications
Trademark applications show the products and services that Kite Pharma is developing and marketing.
Kite Pharma's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
IMMENSI-T Providing health and medical information
08/25/2023
CAR T & ME Educational services in the field of oncology and cell therapy
08/18/2023
LET'S CHAT CAR T providing medical information in the fields of cell therapy and oncology; providing information in the field of cancer treatments
08/22/2022
See all trademarks and details in the Full Report.
Market Share of Kite Pharma's Largest Competitors
A competitive analysis shows these companies are in the same general field as Kite Pharma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Kite Pharma.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Kite Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.